Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Xiang

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Cancer Immunology, Immunotherapy : CII|June 11, 2011
Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunityManjunatha Ankathatti Munegowda, Yulin Deng, Sean J Mulligan, et al.
Experimental Oncology|April 7, 2005
A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cellsSiguo Hao, Liping Su, Xulin Guo, et al.
Cellular & Molecular Immunology|May 9, 2007
Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunityTianpei He, Chaoke Tang, Shulin Xu, et al.
Biochemical and Biophysical Research Communications|July 24, 2013
Natural CD8⁺25⁺ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanomaYufeng Xie, Xueshu Zhang, Tuo Zhao, et al.
Cancer Investigation|March 10, 2010
Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesisYufeng Xie, Weihua Sheng, Jim Xiang, et al.
Immunotargets and Therapy|July 4, 2017
CD8<sup>+</sup> memory T-cell inflation renders compromised CD4<sup>+</sup> T-cell-dependent CD8<sup>+</sup> T-cell immunity via naïve T-cell anergyAizhang Xu, Andrew Freywald, Yufeng Xie, et al.
Leukemia Research|August 23, 2002
Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunityYongqing Liu, Weidong Zhang, Tim Chan, et al.
The Journal of Gene Medicine|August 5, 2004
Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumorsYongqing Liu, Anurag Saxena, Changyu Zheng, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacityZhenmin Ye, Zhuang Chen, Amer Sami, et al.
Biochemical and Biophysical Research Communications|July 10, 2007
Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phaseMeiqing Shi, Zhenmin Ye, Keshav Sokke Umeshappa, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|June 11, 2011
Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunityManjunatha Ankathatti Munegowda, Yulin Deng, Sean J Mulligan, et al.
Experimental Oncology|April 7, 2005
A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cellsSiguo Hao, Liping Su, Xulin Guo, et al.
Cellular & Molecular Immunology|May 9, 2007
Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunityTianpei He, Chaoke Tang, Shulin Xu, et al.
Biochemical and Biophysical Research Communications|July 24, 2013
Natural CD8⁺25⁺ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanomaYufeng Xie, Xueshu Zhang, Tuo Zhao, et al.
Cancer Investigation|March 10, 2010
Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesisYufeng Xie, Weihua Sheng, Jim Xiang, et al.
Immunotargets and Therapy|July 4, 2017
CD8<sup>+</sup> memory T-cell inflation renders compromised CD4<sup>+</sup> T-cell-dependent CD8<sup>+</sup> T-cell immunity via naïve T-cell anergyAizhang Xu, Andrew Freywald, Yufeng Xie, et al.
Leukemia Research|August 23, 2002
Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunityYongqing Liu, Weidong Zhang, Tim Chan, et al.
The Journal of Gene Medicine|August 5, 2004
Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumorsYongqing Liu, Anurag Saxena, Changyu Zheng, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacityZhenmin Ye, Zhuang Chen, Amer Sami, et al.
Biochemical and Biophysical Research Communications|July 10, 2007
Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phaseMeiqing Shi, Zhenmin Ye, Keshav Sokke Umeshappa, et al.
Pageof 17